US 10047082
Octahydro fused azadecalin glucocorticoid receptor modulators
granted A61PA61P35/00
Quick answer
US patent 10047082 (Octahydro fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00